- DEAN OF INTERNATIONAL CLINICAL AFFILIATIONS
- PROFESSOR | Medicine, Cardiology
- Indian (Hindi)
- Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Mount Sinai St. Luke's and Mount Sinai West
- Cardiovascular Medicine Associates 212-241-0884212-241-0884
Dr. Samin K. Sharma is well known for performing maximum number of complex coronary interventions in the country with highest success rates while achieving an extremely low complication rate. According to New York State Department of Health reports (1994-2002, 2006-2008), he has the highest angioplasty success rate and lowest mortality <0.2% for an interventional cardiologist in NY State, receiving prestigious **star designation (significantly lower than expected mortality). Under Dr. Sharma’s leadership, The Mount Sinai Hospital Cardiac Cath Lab has become one of the best and busiest centers in New York, providing state-of-the-art cardiac and interventional care for all types of simple and complex heart patients. In addition to coronary interventions, Dr. Sharma specializes in the non-surgical treatment of mitral and aortic stenosis and transcatheter aortic valve replacement (TAVR).
Dr. Sharma serves on the Cardiac Advisory Board of New York State since 2004 for coronary interventions that advises the Health Department and the Governor on issues of health policies and supervision, safety, and appropriateness of heart care by various hospitals in New York. Dr. Sharma received the Governor’s Award of Excellence (2006), for his outstanding contribution to Medicine.
Dr. Sharma also has passion for teaching and training fellows who enjoy learning from his expertise, so much so they awarded him the Simon Dack Best Teacher in the Division of Cardiology in 2000 and Cardiology Fellows Appreciation Award in 2009. Dr. Sharma travels to India every month to teach the art of angioplasty to Indian cardiologists. He is the vice-president of the Rajasthan Development Foundation and donated medical equipment worth one lakh Rs/month for six years (2001-2007) to the Chief Minister relief fund to help Rajasthan’s people in need. In addition to various academic awards, Dr. Sharma also received numerous awards from nonacademic societies such as the “Rajasthan Gaurav” and “Bharat Gaurav,” given by the Sanskriti organization of Rajasthan and the Rajive Gandhi Memorial Award. Now he has developed a state of the art Heart Hospital (Eternal Heart Care Center, EHCC) in his native place Jaipur, India, which provides excellent care to all kinds of patients, including underprivileged and those living below the poverty level.
Under the directorship of Dr. Sharma, the Live Symposium of Complex Coronary & Vascular Cases (www.cccsympsoium.org) started in 1998 and has had overwhelming attendance every year (attended by >800 delegates). Major emphasis of the live course has been the technical aspects of safely performing complex coronary interventions. In July 2009, Dr. Sharma launched a monthly live web series, (www.ccclivecases.org), a revolutionary teaching tool in nterventional cardiology globally. This live program focuses on helping the audience understandthe complexity of interventional disease management. Each webcast receives >5000 page views globally.
A regular fixture on international, national, and local TV stations, newspapers and magazines, Dr. Sharma has been the focus of news stories for media outlets like: The Today Show, CBS News, NBC News, Fox News, PIX11, The New York Times, The Wall Street Journal, New York Magazine, Reuters, Businessweek, Cardiology Today, India Abroad, India Today, Barron’s, Forbes, Newsweek, The Washington Post, Crain’sNew York Business, NY Daily News, Newsday and New York Post.
Dr. Sharma has been the recipient of numerous awards for excellence from medical societies and the community, to name a few recent ones: 2014 Physician Scientist Award by AAPI-QLI, 2011 Ellis Island Medal of Honor, 2011 American Heart Association Achievement in Cardiovascular Science & Medicine Award, 2011 American Association of Physicians of Indian Origin (AAPI), 2010 Association of Indians in America (AIA) for Excellence in Medicine, 2010 Honored by AAPI forum of Tri-State Area for Academic Excellence, 2005-2008 and 2011-2015 Best Doctors, 2008-2015 Super Doctors, 2007 Jacobi Medallion Award at The Mount Sinai Hospital, 2007 Physician of the Year at The Mount Sinai Hospital.
Dr. Sharma received his medical degree from S.M.S. Medical College in 1978, Jaipur, India, where he was ranked the number one student in his medical school and State University receiving eight gold medals and five honors. In 1983, he came to New York to undergo residency in Internal Medicine at the NY Infirmary-Beekman Downtown Hospital (1983-1986), fellowship in Cardiology in Elmhurst Hospital (1986-1988), and interventional training at The Mount Sinai Hospital (1988-1990). He was then appointed as an attending at The Mount Sinai Hospital in 1990 where he is currently the Director of Interventional Cardiology (since 1996), Director of Clinical Cardiology (since 2011), Dean of International Clinical Affiliations (since 2011), President of Mount Sinai Heart Network (since 2011) and is the Zena and Michael A. Wiener Professor of Medicine, Cardiology (since 2002). He has authored over 200 articles, 420 abstracts, 15 book chapters and three books to his credit.
American Board of Internal Medicine
- Acute Coronary Syndrome
- Heart Attack/Acute Coronary Syndrome
- Valvular Heart Disease
MD, Medical College Jaipur
Residency, Internal Medicine
New York University Downtown Hosp.
City Hospital Center at Elmhurst
English, Indian (Hindi)
America's Top Doctors
Jacobi Medallion Award
Mount Sinai Physician of the Year Award
Governor's Award of Excellence
New York Magazine Best Doctors
Zena and Michael A. Wiener Professor of Medicine
Simon Dack Award for Best Teacher at Cardiovascular Institute
The Mount Sinai Hospital
Best medical and chief resident
NY Infirmary-Beekman Downtown Hospital
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study
This is a prospective, open-label, multi-center, observational, single arm registry designed to evaluate XIENCE V EECSS continued safety and effectiveness on subjects for clinical use (after FDA approval). Only XIENCE V EECSS stents are received during procedure (stent...
Future Revascularization Evaluation in Patients with Diabetes Mellitus:Optimal Management of Multivessel Disease (FREEDOM Trial)
The purpose of this study is to compare two different types of treatment for blocked arteries in the heart. The first treatment is called CABG (Coronary Artery Bypass Graft) surgery where a surgeon puts new vessels into the heart to get around a blocked artery. The second type of...
A Prospective, Two-Arm, Open-Label, Multi-Center Registry using XIENCE PRIME EECSS and XIENCE PRIME LL EECSS (SPIRIT-PRIME)
The purpose of this study is to see if the XIENCE PRIME stent is a safe and effective treatment for the narrowing of heart arteries. This trial will use the drug-coated stents named the XIENCE PRIME and XIENCE PRIME LL Everolimus Eluting Coronary Stent System, which will be calle...
A Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety And Effectiveness of the Tryton Side Branch Stent™ used in Conjunction with a Drug-Eluting Stent Compared to Side Branch Balloon Angioplasty in Conjunction with a Drug-Eluting Stent in the Treatment of de novo Bifurcation Lesions Involving the Main Branch and Side Branch within the Native Coronary Circulation (TRYTON side-branch stent TRIAL)
The purpose of this clinical study is to evaluate the safety and effectiveness of the Tryton Side Branch investigational stent. This study will evaluate a new stent design that is designed to treat narrowing in coronary arteries that occur in the main body of the coronary artery ...
Hannan E, Racz M, Holmes D, King S, Jones R, Ambrose J, Sharma S, Katz S, Clark L, Walford G. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 2006; 113: 2406-2412.
Sharma S, Kini A, Mares A, Tamburino F. Improved outcome with AngioJet thrombectomy during primary stenting in acute myocardial infarction patients with high-grade thrombus. J Invasive Cardiol 2006; 18: 8C-11C.
Sharma S. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large. Cathet Cardiovasc Interv 2005; 65: 10-16.
Agarwal A, Kini A, Attanti S, Sharma S, Ashtiani R, Steinheimer A, Moreno P, Lee P. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol 2005; 95: 43-47.
Lee P, Kini A, Sharma S, Fisher E, Ashan C. Anemia as a risk factor for Percutaneous Coronary Intervention. J Am Coll Cardiol 2004; 44: 541.
Erdel C, Sharma S, Marmur J, Kini A. The current status of rotational atherectomy. Cathet Cardiovasc Interv 2004; 62: 485.
Kim M, Sharma S, Kini A. Therapeutic options in patients with refractory angina. J Am Coll Cardiol 2002; 39: 923.
Kini A, Sharma S, Mitre C, Reich D. A risk stratification scheme for selection of a glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention based on clinical and angiographic criteria. Am J Cardiol 2001; 88: 1287.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Sharma during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Eternal Heart Care Centre and Research Institute Private Limited (EHCRI)
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Abbott Laboratories
- AngioScore, Inc.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc. (CSI)
- Daiichi-Sankyo Co., Ltd. / Eli Lilly and Company Partnership
- Medtronic, Inc.
- The Medicines Company
Scientific Advisory Board:
- Cardiovascular Systems, Inc. (CSI)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.